Showing results (1761-1770 of 2,609) with videos related to

Sort By:
Pageof 261
Oncology Research|August 23, 2018
Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin PathwayLiwei Jia, Dongying Lv, Shuang Zhang, et al.
Oncology Research|January 27, 2025
KHSRP promotes cancer stem cell maintenance, tumorigenesis, and suppresses anti-tumor immunity in gastric cancerYaru DU, Zhihui Pei, Shuqin Hu, et al.
Oncology Research|January 27, 2025
Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interactionJunwei DU, Qiang Zhang, Jing Zhang, et al.
Oncology Research|January 27, 2025
EMP2 promotes hepatocellular carcinoma proliferation and invasion by activating cellular autophagyHaiying Pang, Fengbo Wu, Y U Zhang, et al.
Oncology Research|January 27, 2025
Melanoma-derived extracellular vesicles transfer proangiogenic factorsMagdalena Wilczak, Magdalena Surman, MAłGORZATA PRZYBYłO
Oncology Research|January 27, 2025
Loss of Arhgap39 facilitates cell migration and invasion in murine hepatocellular cancer cellsHung-Wei Lin, Pei Yu Lee, Yu-Shiuan Chang, et al.
Oncology Research|March 20, 2025
Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2V617F mutation in myeloproliferative neoplasmsMohammad Abohassan, Mesfer Mohammad Al Shahrani, Sarah Khaled Alouda, et al.
Oncology Research|March 20, 2025
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancerBelardinilli Francesca, Michela DE Meo, Francesco Del Giudice, et al.
Oncology Research|March 20, 2025
Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progressionBaoxing Huang, Zichang Jia, Chenchen Fu, et al.
Oncology Research|March 20, 2025
A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinomaK E Tian, Zhipeng Li, Xiangyu Zhai, et al.
Pageof 261